Literature DB >> 21519908

LKB1 signaling in advancing cell differentiation.

Lina Udd1, Tomi P Mäkelä.   

Abstract

The Peutz-Jeghers syndrome (PJS) culprit kinase LKB1 phosphorylates and activates multiple intracellular kinases regulating cell metabolism and polarity. The relevance of each of these pathways is highly variable depending on the tissue type, but typically represents functions of differentiated cells. These include formation and maintenance of specialized cell compartments in nerve axons, swift refunneling of metabolites and restructuring of cell architecture in response to environmental cues in committed lymphocytes, and ensuring energy-efficient oxygen-based energy expenditure. Such features are often lost or reduced in cancer cells, and indeed LKB1 defects in PJS-associated and sporadic cancers and even the benign PJS polyps lead to differentiation defects, including expansion of partially differentiated epithelial cells in PJS polyps and epithelial-to-mesenchymal transition in carcinomas. This review focuses on the involvement of LKB1 in the differentiation of epithelial, mesenchymal, hematopoietic and germinal lineages.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21519908     DOI: 10.1007/s10689-011-9441-2

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  125 in total

1.  JNK pathway mediates apoptotic cell death induced by tumor suppressor LKB1 in Drosophila.

Authors:  J H Lee; H Koh; M Kim; J Park; S Y Lee; S Lee; J Chung
Journal:  Cell Death Differ       Date:  2005-11-04       Impact factor: 15.828

2.  Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters.

Authors:  T M Tassava; T Okuda; D R Romsos
Journal:  Am J Physiol       Date:  1992-03

3.  Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice.

Authors:  Hiroyuki Miyoshi; Masayuki Nakau; Tomo-o Ishikawa; Michael F Seldin; Masanobu Oshima; Makoto M Taketo
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

4.  Adenosine 5'-monophosphate-activated protein kinase-mammalian target of rapamycin cross talk regulates brown adipocyte differentiation.

Authors:  Rocio Vila-Bedmar; Margarita Lorenzo; Sonia Fernández-Veledo
Journal:  Endocrinology       Date:  2010-02-04       Impact factor: 4.736

Review 5.  Regulation of thymocyte differentiation: pre-TCR signals and beta-selection.

Authors:  Alison M Michie; Juan Carlos Zúñiga-Pflücker
Journal:  Semin Immunol       Date:  2002-10       Impact factor: 11.130

6.  The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells.

Authors:  Catherine E Gleason; Danhong Lu; Lee A Witters; Christopher B Newgard; Morris J Birnbaum
Journal:  J Biol Chem       Date:  2007-02-07       Impact factor: 5.157

7.  Snrk-1 is involved in multiple steps of angioblast development and acts via notch signaling pathway in artery-vein specification in vertebrates.

Authors:  Chang Z Chun; Sukhbir Kaur; Ganesh V Samant; Ling Wang; Kallal Pramanik; Maija K Garnaas; Keguo Li; Lyndsay Field; Debabrata Mukhopadhyay; Ramani Ramchandran
Journal:  Blood       Date:  2008-08-22       Impact factor: 22.113

Review 8.  Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma.

Authors:  David González; Mirjam van der Burg; Ramón García-Sanz; James A Fenton; Anton W Langerak; Marcos González; Jacques J M van Dongen; Jesus F San Miguel; Gareth J Morgan
Journal:  Blood       Date:  2007-07-18       Impact factor: 22.113

9.  Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation.

Authors:  Afshan McCarthy; Christopher J Lord; Kay Savage; Anita Grigoriadis; Darrin P Smith; Britta Weigelt; Jorge S Reis-Filho; Alan Ashworth
Journal:  J Pathol       Date:  2009-11       Impact factor: 7.996

10.  Lkb1 deficiency alters goblet and paneth cell differentiation in the small intestine.

Authors:  Boris Y Shorning; Joanna Zabkiewicz; Afshan McCarthy; Helen B Pearson; Douglas J Winton; Owen J Sansom; Alan Ashworth; Alan R Clarke
Journal:  PLoS One       Date:  2009-01-23       Impact factor: 3.240

View more
  7 in total

1.  MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.

Authors:  Te Liu; Wenxing Qin; Lengchen Hou; Yongyi Huang
Journal:  Tumour Biol       Date:  2014-12-16

2.  Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation.

Authors:  Lick Pui Lai; Brendan N Lilley; Joshua R Sanes; Andrew P McMahon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

3.  Significant correlation between LKB1 and LGR5 gene expression and the association with poor recurrence-free survival in rectal cancer after preoperative chemoradiotherapy.

Authors:  Susumu Saigusa; Yasuhiro Inoue; Koji Tanaka; Yuji Toiyama; Mikio Kawamura; Yoshinaga Okugawa; Masato Okigami; Junichiro Hiro; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-18       Impact factor: 4.553

4.  Stk11 (Lkb1) deletion in the osteoblast lineage leads to high bone turnover, increased trabecular bone density and cortical porosity.

Authors:  Lick Pui Lai; Sutada Lotinun; Mary L Bouxsein; Roland Baron; Andrew P McMahon
Journal:  Bone       Date:  2014-09-18       Impact factor: 4.398

5.  LKB1/ STK11, Peutz-Jeghers syndrome and cancer. Introduction.

Authors:  Fred H Menko
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

6.  Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection.

Authors:  Dezhi Li; Yu Zhou; Yanhui Liu; Ye Lin; Min Yu; Xin Lu; Bowen Huang; Zhonghai Sun; Zhixiang Jian; Baohua Hou
Journal:  Onco Targets Ther       Date:  2018-03-06       Impact factor: 4.147

7.  LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer.

Authors:  Christopher W Murray; Jennifer J Brady; Mingqi Han; Hongchen Cai; Min K Tsai; Sarah E Pierce; Ran Cheng; Janos Demeter; David M Feldser; Peter K Jackson; David B Shackelford; Monte M Winslow
Journal:  Nat Commun       Date:  2022-02-28       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.